Flow cytometry, a marvel of biomedical technology, invites us to delve into the microcosm of our own bodies. By probing the properties and compositions of individual cells, we unravel the stories they tell about our health and diseases. Amongst these tales, the narrative of acute leukemia - a group of malignant disorders characterized by the rapid proliferation of immature blood cells - often necessitates a thorough exploration.
Profile Name Flowcytometry Panel - Acute Leukemia Comprehensive Characterization
Sample Type Blood, Bone Marrow
Preparations Required No specific preparations such as fasting or water restrictions are necessary. However, inform your doctor about any medications, supplements or therapies you are currently taking.
Report Time 24 hours
The Acute Leukemia Comprehensive Characterization in flow cytometry aids in this expedition. Using a constellation of markers, such as CD45, CD34, CD38, TdT, CD19, CD20, CD22, CD10, CD79a, Kappa, Lambda, CD1a, CD2, CD3, CD4, CD5, CD7, CD8, CD13, CD33,CD56, CD64, CD117, CD123, Glycophorin A, MPO, CD11b, HLA-DR, CD14, CD15, CD16, CD41, CD61, CD71, it paints a comprehensive picture of the cell populations in blood or bone marrow samples. This information is indispensable for diagnosing, classifying, and monitoring acute leukemia, and for charting a precise course of treatment.
Home Sample Collection Process
1
Book your convenient slot
2
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
4
Download Reports
Note: Home Sample Collection is only for Pathology lab tests.
Frequently Asked Questions
This panel plays a crucial role in diagnosing and monitoring acute leukemia. It also aids in classifying
the disease into specific types, influencing the choice of treatment, and assessing the response to
therapy.
No, fasting is not necessary before this test. However, always follow your doctor's instructions.
This test measures the presence and quantity of various cellular markers on the surface or inside of
blood or bone marrow cells. It helps to identify and categorize the abnormal cell populations
characteristic of acute leukemia.
The frequency of this test is determined by your doctor based on your specific condition. It's usually
performed at diagnosis, periodically during treatment, and to monitor for disease recurrence.
Normal values can vary widely as this test measures a broad range of cellular markers. Your doctor will
interpret the results in the context of your health condition and clinical symptoms.
No specific precautions are needed. It's important to inform your doctor about any medications or
supplements you're currently taking as they might influence the test results.
Factors affecting the results can include certain medications, other blood disorders, and your overall
health status. Some factors are modifiable, such as dietary and lifestyle habits, while others, like
genetics, are non-modifiable.
If your results are abnormal, you should consult with a hematologist or an oncologist, doctors
specializing in blood disorders and cancer, respectively. They will provide further guidance based on
your specific results and overall health condition.
The test involves a blood or bone marrow draw, which carries minor risks like bruising or infection at
the needle site. More serious complications are rare.
An abnormal result can indicate acute leukemia, but other tests are typically needed to confirm the
diagnosis. It's important to discuss your results with your doctor.
Yes, certain medications can affect the results of this test. It's important to inform your doctor about
all medications and supplements you're taking.
While acute leukemia can't be prevented, a healthy lifestyle can support overall health and wellbeing.
Regular medical check-ups can also aid in early detection of health issues.
Treatment options for acute leukemia can include chemotherapy, targeted therapy, immunotherapy, stem cell
transplantation, and supportive care. The choice of treatment depends on the specific type of leukemia
and patient factors.
Some forms of acute leukemia have a genetic component and may potentially be detected through prenatal
genetic testing. However, most forms of acute leukemia are not hereditary and cannot be detected before
birth.
The impact on lifespan depends on the specific type and stage of acute leukemia, the effectiveness of
treatment, and other individual health factors. Early detection and appropriate treatment can improve
the prognosis.
The Acute Leukemia Comprehensive Characterization in flow cytometry is like a high-resolution map of an otherwise invisible terrain - the world of our cells. It's in this cellular world that the story of acute leukemia unfolds, and understanding this narrative is pivotal to winning the battle against the disease. As we continue to refine this tool and interpret its language, we open new avenues for personalized medicine, transforming the fight against leukemia into a journey of hope and healing.
